Systemic screening of milk protein-derived ACE inhibitors through a chemically synthesised tripeptide library

Food Chemistry

Volumn 128, Issue 3, 2011, Pages 761-768

  Ren, Fazheng ^a,b,c   Zhang, Shunliang ^a,b,c   Guo, Huiyuan ^a,b,c   Jiang, Lu ^a,b,c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Beijing Higher Institution Engineering Research Center of Animal Product   (China)

Author keywords

Angiotensin converting enzyme; Solid phase synthesis; System screening; Tripeptide library

Indexed keywords

ACE INHIBITORS; ACE-INHIBITORY ACTIVITY; ANGIOTENSIN-CONVERTING ENZYME; INHIBITORY ACTIVITY; L-LEUCINE; LACTOGLOBULIN; MILK PROTEIN; RELATIVE ACTIVITIES; SOLID-PHASE SYNTHESIS; SYSTEM SCREENING; TRI-PEPTIDES; TRIPEPTIDE;

AMINO ACIDS; CASEIN;

ENZYMES;

BETA LACTOGLOBULIN; CASEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEUCINE; MILK PROTEIN; TRIPEPTIDE;

ARTICLE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; PROTEIN SYNTHESIS; SYNTHESIS;

BOVINAE;

EID: 79955585445     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2011.03.108     Document Type: Article

References (30)

1. Alonso, A., Steffen, L. M., & Folsom, A. R. (2009). Dairy intake and changes in blood pressure over 9 years: The ARIC study. European Journal of Clinical Nutrition, 63, 1272-1275.
2. Anzenbacherova, E., Anzenbacher, P., Macek, K., & Kvetina, J. (2001). Determination of enzyme (angiotensin convertase) inhibitors based on enzymatic reaction followed by HPLC. Journal of Pharmaceutical and Biomedical Analysis, 24, 1151-1156. (Pubitemid 32209177)
3. Aurup, P. (1997). Tackling ACE-inhibitor cough. Lancet, 350, 1854-1855.
4. Bonazzi, D., Gotti, R., Andrisano, V., & Cavrini, V. (1997). Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). Journal of Pharmaceutical and Biomedical Analysis, 16, 431-438. (Pubitemid 27514385)
5. Carlene, M. M., Stephen, V. H., & Anthony, R. (2008). Global burden of bloodpressure-related disease, 2001. Lancet, 371, 1513-1518.
6. Chan, W. C., & White, P. D. (2004). Basic procedures. In W. C. Chan & P. D. White (Eds.), Fmoc solid phase peptide synthesis (pp. 41-76). New York: Oxford University Press Inc..
7. Clark, M. (2008). Diabetes self-management education: A review of published studies. Primary Care Diabetes, 2, 113-120.
8. Coates, D. (2003). The angiotensin converting enzyme (ACE). International Journal of Biochemistry and Cell Biology, 35, 769-773.
9. Dutta, A. S. (1993). Small peptides, chemistry, biology and clinical studies. Pharmco chemistry library 19, Amsterdam: Elsevier.
10. Ezzati, M., Lopez, A. D., Rodgers, A., Vander, Hoorn S., & Murray, C. J. (2002). Selected major risk factors and global and regional burden of disease. Lancet, 360, 1347-1360. (Pubitemid 35341298)
11. FitzGerald, R. J., Murray, B. A., & Walsh, D. J. (2004). Hypotensive peptides from milk proteins. Journal of Nutrition, 134, 980-988.
12. Flather, M. D., Yusuf, S., Køber, L., Pfeffer, M., Hall, A., Murray, G., et al. (2000). Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. Lancet, 355, 1575-1581. (Pubitemid 30240501)
13. Jäkälä, P., & Vapaatalo, H. (2010). Antihypertensive peptides from milk proteins. Pharmaceuticals, 3, 251-272.
14. Kompella, U. B., & Lee, V. H. L. (2001). Delivery systems for penetration enhancement of peptide and protein drugs: Design considerations. Advanced Drug Delivery Reviews, 46, 211-245. (Pubitemid 33653423)
15. Krousel-Wood, M. A., Muntner, P., He, J., & Whelton, P. K. (2004). Primary prevention of essential hypertension. Medical Clinics of North America, 88, 223-238. (Pubitemid 38160947)
16. Lee, J. E., Bae, I. Y., Lee, H. G., & Yang, C. B. (2006). Tyr-Pro-Lys, an angiotensin I-converting enzyme inhibitory peptide derived from broccoli (Brassica oleracea Italica). Food Chemistry, 99, 143-148.
17. Leibach, F. H., & Ganapathy, V. (1996). Peptide transporters in the intestine and the kidney. Annual Review of Nutrition, 16, 99-119. (Pubitemid 26286848)
18. Meng, Q. C., King, S. J., Branham, K. E., DeLucas, L. J., Lorber, B., & Oparil, S. (1992). Preparative isolation of angiotensin-converting enzyme from human lung. Journal of Chromatography B, 579, 63-71.
19. Meng, Q. C., & Oparil, S. (1996). Purification and assay methods for angiotensin-converting enzyme. Journal of Chromatography A, 743, 105-122. (Pubitemid 26316386)
20. Merrifield, B. (1986). Solid phase synthesis. Science, 232, 341-347.
21. Miguel, M., Contreras, M. M., Recio, I., & Aleixandre, A. (2009). ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry, 112, 211-214.
22. Moukarbel, G. V., & Solomon, S. D. (2008). Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Evidence from clinical trials. Current Heart Failure Reports, 5, 197-203.
23. Papadimitriou, C. G., Vafopoulou-Mastrojiannaki, A., Silva, S. V., Gomes, A. M., Malcata, F. X., & Alichanidis, E. (2007). Identification of peptides in traditional and probiotic sheep milk yoghurt with angiotensin I-converting enzyme (ACE)-inhibitory activity. Food Chemistry, 105, 647-656. (Pubitemid 47048559)
24. Pihlanto, A., Virtanen, T., & Korhonen, H. (2010). Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. International Dairy Journal, 20, 3-10.
25. Roberts, P. R., & Zaloga, G. P. (1994). Dietary bioactive peptides. New Horiz, 2, 237-243.
26. Robinson, T. D., Celermajer, D. S., & Bye, P. T. P. (1997). How to stop ACE-inhibitor-induced cough. Lancet, 350, 3-4. (Pubitemid 27279758)
27. Wang, L., Manson, J. E., Buring, J. E., Lee, I. M., & Sesso, H. D. (2008). Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension, 51, 1073-1079. (Pubitemid 351398988)
28. World Health Organisation (2003). Diet, nutrition and the prevention of chronic diseases 2003. Geneva, Switzerland: World Health Organisation [WHO technical report series no. 916].
29. Wu, J. P., Aluko, R. E., & Nakai, S. (2006). Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship study of di- and tripeptide. Journal of Agricultural and Food Chemistry, 54, 732-738. (Pubitemid 43274109)
30. Wu, J. P., & Ding, X. L. (2002). Characterization of inhibition and stability of soyprotein-derived angiotensin I-converting enzyme inhibitory peptides. Food Research International, 35, 367-375.